Congress may soon require drug, device companies to disclose payments to nurse practitioners and other clinicians

WASHINGTON — Drug companies and medical device manufacturers would have to disclose payments and gifts made to nurse practitioners and physician assistants beginning in 2020 as part of a new law Congress is likely to finalize within days, significantly expanding a sunshine law that previously only applied to doctors.

The new rules would also apply to clinical nurse specialists, nurse-anesthetists, and nurse-midwives.

The provision would significantly expand a previous transparency law approved in 2010 and implemented in 2013, which mandated that medical product companies disclose the same information — but only regarding their payments and gifts to physicians, often made in exchange for speaking and consulting services.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In